Effects of airway calibre on lung delivery of nebulised salbutamol

Lipworth, B. J.; Clark, D. J.
December 1997
Thorax;Dec1997, Vol. 52 Issue 12, p1036
Academic Journal
No abstract available.


Related Articles

  • Potential hazard of nebulised salbutamol in patients with haemoptysis.  // British Medical Journal (Clinical Research Edition);3/12/1983, Vol. 286 Issue 6368, p844 

    Investigates the potential hazard of nebulised salbutamol in patients with haemoptysis. Physiologic effects of salbutamol; Citation of a case report on a patient with bronchiectasis; Effects of intercurrent infection on intermittent haemoptysis and bronchiectasis.

  • Nebulisation of Receptor-Targeted Nanocomplexes for Gene Delivery to the Airway Epithelium. Manunta, Maria D. I.; McAnulty, Robin J.; Tagalakis, Aristides D.; Bottoms, Stephen E.; Campbell, Frederick; Hailes, Helen C.; Tabor, Alethea B.; Laurent, Geoffrey J.; O'Callaghan, Christopher; Hart, Stephen L. // PLoS ONE;2011, Vol. 6 Issue 10, p1 

    Background: Gene therapy mediated by synthetic vectors may provide opportunities for new treatments for cystic fibrosis (CF) via aerosolisation. Vectors for CF must transfect the airway epithelium efficiently and not cause inflammation so they are suitable for repeated dosing. The inhaled...

  • Nebuliser hood compared to mask in wheezy infants: aerosol therapy without tears! Amirav I; Balanov I; Gorenberg M; Groshar D; Luder A S // Archives of Disease in Childhood;Aug2003, Vol. 88 Issue 8, p719 

    BACKGROUND: Small volume nebulisers (SVNs) with masks commonly provide aerosol therapy for infants with lung diseases. However, infants and toddlers are often disturbed by and thus reject masks. AIMS: To compare the lung deposition efficiency of the "usual" SVN aerosol mask and a prototype hood...

  • Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis. Byrne N M; Keavey P M; Perry J D; Gould F K; Spencer D A // Archives of Disease in Childhood;Aug2003, Vol. 88 Issue 8, p715 

    AIM: To examine the effectiveness of delivery of nebulised colistin by the HaloLite nebuliser compared to the Pari LC Plus in patients with cystic fibrosis. METHODS: Randomised crossover trial of 15 patients aged >6 years. Inhalation of one mega unit of colistin in 3 ml diluent, labelled with...

  • The pharmacokinetics of levosalbutamol: what are the clinical implications? Boulton, D.W.; Fawcett, J.P. // Clinical Pharmacokinetics;2001, Vol. 40 Issue 1, p23 

    Salbutamol (albuterol) is a β-adrenoceptor agonist used as a bronchodilator for the treatment of asthma and as a uterine relaxant for the suspension of premature labour. Salbutamol has been marketed as a racemic mixture, although β-agonist activity resides almost exclusively in the...

  • The effects of jet nebulisation on cationic liposome-mediated gene transfer in vitro. Stern, M; Sorgi, F; Hughes, C; Caplen, N J; Browning, J E; Middleton, P G; Gruenert, D C; Farr, S J; Huang, L; Geddes, D M; Alton, E W F W // Gene Therapy;May98, Vol. 5 Issue 5, p583 

    Nebulisation is currently the most acceptable and practical delivery system for repeated applications of gene therapy to the lower airways of cystic fibrosis (CF) patients. We have assessed whether this route of administration offers other benefits with regard to respiratory gene transfer. A...

  • Relative lung and total systemic bioavailability following inhalation from a metered dose inhaler compared with a metered dose inhaler attached to a large volume plastic spacer and a jet nebuliser. Silkstone, V. L.; Corlett, S. A.; Chrystyn, H. // European Journal of Clinical Pharmacology;Jan2002, Vol. 57 Issue 11, p781 

    Objective: To compare the lung and systemic delivery of salbutamol following inhalation from a metered dose inhaler (MDI), a MDI attached to a spacer (MDI+SP) and a nebuliser (NEB) using a urinary pharmacokinetic method. Method: Twelve healthy subjects each provided urine samples at 0, 30 min...

  • Comparison of intravenous and nebulised salbutamol in initial treatment of severe asthma. Lawford, P.; Jones, B.J.M.; Milledge, J.S. // British Medical Journal;1/14/1978, Vol. 1 Issue 6105, p84 

    Salbutamol has been assessed in the initial treatment of acute severe, asthma[1, 2] but the optimum route and duration of administration have not been established. We have compared the effects of salbutamol given by intravenous infusion with those of wet, nebulised salbutamol in a randomised,...

  • Inhalation of β2 agonists impairs the clearance of nontypable Haemophilus influenzae from the murine respiratory tract. Maris, Nico A.; Florquin, Sandrine; Van't Veer, Cornelis; De Vos, Alex F.; Buurman, Wim; Jansen, Henk M.; Van der Poll, Tom // Respiratory Research;2006, Vol. 7, p1 

    Background: Nontypable Haemophilus influenzae (NTHi) is a common bacterial pathogen causing human respiratory tract infections under permissive conditions such as chronic obstructive pulmonary disease. Inhalation of β2-receptor agonists is a widely used treatment in patients with chronic...

  • Salbutamol MDIs: cost saving in paediatric ED.  // PharmacoEconomics & Outcomes News;5/29/2010, Issue 604, p3 

    The article discusses research on the cost-effectiveness of salbutamol metered dose inhalers (MDIs), which references the study "Cost Effectiveness of Metered Dose Inhalers Versus Nebulisers in the Treatment of Asthma in the Pediatric Emergency Department," by Q. H. Doan et al.


Read the Article


Sign out of this library

Other Topics